medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2022, Number 4

<< Back Next >>

Rev Latin Infect Pediatr 2022; 35 (4)

Pediatric multisystemic inflammatory syndrome associated with COVID: series of 5 cases

Solís SAC, Ruíz CJE, Rodríguez MFI, Cauich SJN

Language: Spanish
References: 26
Page: 167-175
PDF size: 353.34 Kb.


ABSTRACT

Since the beginning of the SARS-CoV-2 pandemic, a variable clinical spectrum has been identified in the pediatric population, ranging from completely asymptomatic, mild signs of upper respiratory infection to an acute multisystem inflammatory condition that led to multiple organ failure and shock, sharing characteristics with Kawasaki disease, called multisystem inflammatory syndrome (MIS-C). In the Regional Hospital "Elvia Carrillo Puerto" of the ISSSTE in Mérida, Yucatán, five previously healthy male patients with a diagnosis of MIS-C have been admitted, with an age range between one month and 10 years, 100% presented with irritability and fever with a mean duration of 4.8 days, 60% presented with abdominal pain, vomiting and rash, 40% manifested pulmonary symptoms. In laboratory studies, leukocytosis, lymphopenia, hypoalbuminemia, hyponatremia, high procalcitonin, elevated D-dimer, and evidence of SARS-CoV-2 infection were observed. Only four patients were managed with human immunoglobulin (IVIG) 2 g/kg/single dose, all patients were treated with acetylsalicylic acid, steroid and enoxaparin. The mean hospital stay was 8.8 days.


REFERENCES

  1. Goudouris ES. Laboratory diagnosis of COVID-19. J Pediatr (Rio J). 2021; 97 (1): 7-12.

  2. Ciuca IM. COVID-19 in children: an ample review. Risk Manag Healthc Policy. 2020; 13: 661-669.

  3. Rodríguez-Herrera R, Rivera-Díaz M. Síndrome inflamatorio multisistémico asociado a COVID-19 en niños y adolescentes. Rev Latin Infect Pediatr. 2020; 33 (3): 115-118.

  4. Aquino-Villagómez DY, Pila-Aranda G, González-Agosto A, Anzaldo-Campos MC, Pasarín-Montes JL, Martínez-Arce PA et al. Síndrome inflamatorio multisistémico pediátrico por SARS-CoV-2 (MIS-C). Experiencia de un Hospital de segundo nivel en Tijuana, Baja California, México. Bol Clin Hosp Infant Edo Son. 2020; 37 (2): 78-86.

  5. Pousa PA, Mendonça TSC, Oliveira EA, Simões-E-Silva AC. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations. J Pediatr (Rio J). 2021; 97 (2): 116-139.

  6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020; 323 (13): 1239-1242.

  7. De Coll-Vela LE, Zamudio-Aquise MK, Nuñez-Paucar H, Bernal-Mancilla RR, Schult-Montoya SC, Ccorahua-De La Paz M et al. Síndrome inflamatorio multisistémico asociado a COVID-19 en niños: serie de casos en un hospital pediátrico de Perú. Rev Perú Med Exp Salud Publica. 2020; 37 (3): 559-565.

  8. Carrasco CA, Cuatecontzi RA, Zárate MCA, Grajales MAC, Ramírez PLR. Enfermedad de Kawasaki y SARS-CoV-2, reporte de un caso. Alerg Asma Inmunol Pediatr. 2020; 29 (2): 52-58.

  9. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020; 174 (9): 868-873.

  10. Esposito S, Principi N. Multisystem inflammatory syndrome in children related to SARS-CoV-2. Paediatr Drugs. 2021; 23 (2): 119-129.

  11. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Wkly. 2020; 2 (8): 113-122.

  12. Dirección General de Epidemiología. Datos abiertos COVID-19 [base de datos al 23/07/2021]. México: Secretaría de Salud; 2021.

  13. Sood M, Sharma S, Sood I, Sharma K, Kaushik A. Emerging evidence on multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection: a systematic review with meta-analysis. SN Compr Clin Med. 2021; 3 (1): 38-47.

  14. Santos BSD, Santos FSD, Ribeiro ER. Clinical-epidemiological relation between SARS-CoV-2 and Kawasaki disease: an integrative literature. Rev Paul Pediatr. 2021; 39: e2020217.

  15. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395 (10237): 1607-1608.

  16. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020; 395 (10239): 1771-1778.

  17. Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020; 142 (5): 429-436.

  18. Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020; 324 (3): 259-269.

  19. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F et al. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study. BMJ. 2020; 369: m2094.

  20. Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS et sl. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA. 2020; 324 (3): 294-296.

  21. Lima-Setta F, Magalhães-Barbosa MC, Rodrigues-Santos G, Figueiredo EADN, Jacques ML, Zeitel RS et al. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study. J Pediatr (Rio J). 2021; 97 (3): 354-361.

  22. World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 [Internet]. 2020 [Accessed 25 Jun 2020]. Available in: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19

  23. Centers for Disease Control and Prevention Health Alert Network (HAN). Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). 2020 [Accessed 30 Aug 2020]. Available in: https://emergency.cdc.gov/han/2020/han00432.asp

  24. Belot A, Antona D, Renolleau S, Javouhey E, Hentgen V, Angoulvant F, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020; 25 (22): 2001010. doi: 10.2807/1560-7917.ES.2020.25.22.2001010.

  25. Torres JP, Izquierdo G, Acuña M, Pavez D, Reyes F, Fritis A et al. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic. Int J Infect Dis. 2020; 100: 75-81.

  26. Hennon TR, Yu KOA, Penque MD, Abdul-Aziz R, Chang AC, McGreevy MB et al. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves. Prog Pediatr Cardiol. 2021; 62: 101407.




2020     |     www.medigraphic.com